Scott Huennekens will deliver the Keynote address at the 2021 Emerging Medtech Summit. He will also sit on a panel to discuss the current state of Medtech SPACs.
Huennekens is a successful executive, entrepreneur, board member and investor in medical devices having been the start-up CEO of multiple “unicorns” and a part of 10+ startups or growth companies with market valuations that have totaled over $6B and more importantly > 20 million patients that have benefited from the therapies & diagnostics of these companies. He currenty serves as Chairman of the Board for Acutus Medical and Vida FLaSH Acquisitions Corp (Medtech SPAC). Scott served as Pres & CEO of Verb Surgical, Google and J&J’s new Surgical Robotics start-up to revolutionize the future of surgery in January. Previously, Scott led Volcano Corp., as its first and only Pres. & CEO, from start-up in 2002 to its IPO in 2006 and sale to Philips in 2015. Prior to this, he was at Digirad Corporation, a diagnostic imaging solutions provider, from 1997 to 2002, as President & CEO. Digirad went public in 2004 (DRAD). Scott graduated Magna Cum Laude with a BS in Business Administration from the Univ. of Southern California in 1986 and earned his MBA from the Harvard Business School in 1991. Current professional affiliations include Board Member Nuvasive (NUVA), Board Member ViewRay (VRAY), Board Member TDi, Board of Advisors Peloton Ventures, Board Member and past Chairman MDMA.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
